|
1
|
Caine JG, Stonelake PS, Lip GYH and Kehoe
ST: The hypercoagulable state of malignancy: Pathogenesis and
current dabate. Neoplasia. 4:465–473. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carrier M, Lazo-Langner A, Shivakumar S,
Tagalakis V, Zarychanski R, Solymoss S, Routhier N, Douketis J,
Danovitch K, Lee AY, et al: Screening for occult cancer in
unprovoked venous thromboembolism. New Engl J Med. 373:697–704.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abdol Razak NB, Jones G, Bhandari M,
Berndt MC and Metharom P: Cancer-associated thrombosis: An overview
of mechanisms, risk factors, and treatment. Cancers (Basel).
10:3802018. View Article : Google Scholar
|
|
4
|
Aronson D and Brenner B: Arterial
thrombosis and cancer. Thromb Res. 164 (Suppl 1):S23–S28. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lip GYH, Chin BSP and Blann AD: Cancer and
the prothrombotic state. Lancet Oncol. 3:27–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
el-Shami K, Griffiths E and Streiff M:
Nonbacterial thrombotic endocarditis in cancer patients:
Pathogenesis, diagnosis, and treatment. Oncologist. 12:518–523.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mukai M and Oka T: Mechanism and
management of cancer-associated thrombosis. J Cardiol. 72:89–93.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horsted F, West J and Grainge MJ: Risk of
venous thromboembolism in patients with cancer: A systematic review
and meta-analysis. PLoS Med. 9:e10012752012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haddad TC and Greeno EW:
Chemotherapy-induced thrombosis. Thrombo Res. 118:555–568. 2006.
View Article : Google Scholar
|
|
10
|
Connolly G and Francis CW:
Cancer-associated thrombosis. Hematology Am Soc Hematol Educ
Program. 2013:684–691. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raskob GE, van Es N, Verhamme P, Carrier
M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri
MF, et al: Edoxaban for treatment of cancer-associated venous
thromboembolism. N Engl J Med. 378:615–624. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Manual. 8th. Springer; New York,
NY: 2017
|
|
13
|
Coons AH, Creech HJ and Jones RN:
Immunological properties of an antibody containing a fluorescent
group. Exp Biol Med. 47:200–202. 1941. View Article : Google Scholar
|
|
14
|
Vallée A, Le Loupp A-G and Denis MG:
Efficiency of the Therascreen® RGQ PCR kit for the
detection of EGFR mutations in non-small cell lung carcinomas. Clin
Chim Acta. 429:8–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reck M, Rodríguez-Abreu D, Robinson AG,
Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe
S, et al: Pembrolizumab versus chemotherapy for PD-L1-positive
non-small-cell lung cancer. N Engl J Med. 375:1823–1833. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saenger AK, Beyrau R, Braun S, Cooray R,
Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H,
et al: Multicenter analytical evaluation of a high-sensitivity
troponin T assay. Clin Chim Acta. 412:748–754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden
WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB Sr, Elley CR, et
al: International validation of the thrombolysis in myocardial
infarction (TIMI) risk score for secondary prevention in post-MI
patients: A collaborative analysis of the chronic kidney disease
prognosis consortium and the risk validation scientific committee.
J Am Heart Assoc. 7:e0084262018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Layden J, Michaels J, Bermingham S and
Higgins B; Guideline Development Group, : Diagnosis and management
of lower limb peripheral arterial disease: Summary of NICE
guidance. BMJ. 345:e49472012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Quintela AG, Candela MJ, Vidal C, Román J
and Aramburo P: Non-bacterial thrombotic endocarditis in cancer
patients. Acta Cardiol. 46:1–9. 1991.PubMed/NCBI
|
|
20
|
Biller J, Challa VR, Toole JF and Howard
VJ: Nonbacterial thrombotic endocarditis. A neurologic perspective
of clinicopathologic correlations of 99 patients. Arch Neurol.
39:95–98. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barry WE and Scarpelli D: Nonbacterial
thrombotic endocarditis. A clinicopathologic study. Arch Intern
Med. 109:79–84. 1962. View Article : Google Scholar
|
|
22
|
Liu J and Frishman WH: Nonbacterial
thrombotic endocarditis: Pathogenesis, diagnosis and management.
Cardiol Rev. 24:244–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kooiker JC, MacLean JM and Sumi SM:
Cerebral embolism, marantic endocarditis, and cancer. Arch Neurol.
33:260–264. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazokopakis EE, Syros PK and Starakis IK:
Nonbacterial thrombotic endocarditis (marantic endocarditis) in
cancer patients. Cardiovasc Hematol Disord Drug Targets. 10:84–86.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Joffe II, Jacobs LE, Owen AN, Ioli A and
Kotler MN: Noninfective valvular masses: Review of the literature
with emphasis on imaging techniques and management. Am Heart J.
131:1175–1183. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dutta T, Karas MG, Segal AZ and Kizer JR:
Yield of transesophageal echocardiography for nonbacterial
thrombotic endocarditis and other cardiac sources of embolism in
cancer patients with cerebral ischemia. Am J Cardiol. 97:894–898.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abouarab AA, Elmously A, Leonard JR,
Arisha MJ, Gaudino M, Narula N and Salemi A: Nonbacterial trombotic
endocarditis presenting with leg pain and a left atrial mass
lesion. Cardiology. 139:208–211. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Asopa S, Patel A, Khan OA, Sharma R and
Ohri SK: Non-bacterial thrombotic endocarditis. Eur J Cardiothorac
Surg. 32:696–701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee AY, Levine MN, Baker RI, Bowden C,
Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, et
al: Low-molecular-weight heparin versus a coumarin for the
prevention of recurrent venous thromboembolism in patients with
cancer. N Eng J Med. 349:146–153. 2003. View Article : Google Scholar
|
|
30
|
Franco-Moreno A, Cabezòn-Gutierréz L,
Palka-Kotlowsa M, Villamayor-Delgado M and García-Navarro M:
Evaluation of direct oral anticoagulants for the treatment of
cancer-associated thrombosis: An update. J Thromb Thrombolysis.
47:409–419. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fournier JB and Testa EJ: Nonbacterial
thrombotic endocarditis. N Engl J Med. 380:e482019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee RJ, Bartzokis T, Yeoh TK, Grogin HR,
Choi D and Schnittger I: Enhanced detection of intracardiac source
of cerebral emboli by transesophageal echocardiography. Stroke.
22:734–739. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brosseau S, Gounant V, Naltet C,
Théou-Anton N, Cazes A, Smonig R, Neuville M, Khalil A, Mikail N,
Meignin V, et al: Lazarus syndrome with crizotinib in a non-small
cell lung cancer patient with ROS1 rearrangement and disseminated
intravascular coagulation. Clin Lung Cancer. 19:e57–e61. 2018.
View Article : Google Scholar : PubMed/NCBI
|
